Clinical features of patients with multiple myeloma
| Patient no. | Age/Sex | Disease status, Durie-Salmon stage | Treatment | Paraprotein type |
|---|---|---|---|---|
| 1 | 58/M | Refractory | VAD, endoxan | BJP, κ |
| 2 | 69/M | Refractory | MP | IgG, λ |
| 3 | 73/M | Newly diagnosed, stage II | — | IgM, κ |
| 4 | 65/M | Newly diagnosed, stage II | — | IgG, κ |
| 5 | 79/M | Newly diagnosed, stage II | — | IgG, κ |
| 6 | 78/M | Newly diagnosed, stage II | — | IgG, κ |
| 7 | 76/F | Newly diagnosed, stage III | — | IgA, κ |
| 8 | 59/M | Newly diagnosed, stage III | — | IgG, κ |
Abbreviations: VAD, vincristine, adriamycin, dexamethasone; MP, melphalan + prednisolone; M, male; F, female; Ig, immunoglobulin; BJP, Bence Jones protein.